Immuto Scientific closed a $2.3 million seed funding round, the company announced recently. Wisconsin Investment Partners (WIP) led the round, with participation from the Wisconsin Alumni Research Foundation (WARF), Great Oaks…
Semba Biosciences, an innovator in the field of multi-column chromatography (MCC) instrumentation and technology for downstream purification of biologics, has been acquired by Tosoh Bioscience, the company announced recently. “We…
SHINE Medical Technologies has changed its name to SHINE Technologies, the company announced today. According to a release, the new name highlights the company’s core technological competencies, skilled team and…
NorthStar Medical Radioisotopes has been awarded $37 million in cooperative agreement funds with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…
Imbed Biosciences has partnered with Spartan Medical, a company that provides an extensive portfolio of advanced medical devices and technologies from premier partners, the company announced recently. According to a…
Cellectar Biosciences has been awarded a $2 million Phase II National Institutes of Health (NIH) SBIR grant from the National Cancer Institute (NCI), the company announced recently. According to a…
Invenra has expanded its discovery and licensing collaboration with Exelixis to include an additional 20 oncology targets, the company announced today. According to a release, the collaboration builds on the…
NorthStar Medical Radioisotopes and GE Healthcare signed an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules in the United States, NorthStar announced recently. According to a release,…
Cellectar Biosciences and LegoChemBio, a clinical-stage biotechnology company in South Korea, have entered a development and commercialization collaboration, the company announced today. According to a release, the two companies have…
FluGen has been awarded an $11.4 million grant from the United States Department of Defense to conduct a safety and immunogenicity study of the influenza vaccine (M2SR, the company announced…
